MedPath

HYDROGEL

MENTHOL 5% HYDROGEL PATCH

Approved
Approval ID

d127aaae-e2cc-4757-a815-e912fff3bbc3

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Aug 20, 2025

Manufacturers
FDA

Novamed Laboratories Private Limited

DUNS: 766401623

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MENTHOL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code85267-003
Application NumberM017
Product Classification
M
Marketing Category
C200263
G
Generic Name
MENTHOL
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 20, 2025
FDA Product Classification

INGREDIENTS (20)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDInactive
Code: K679OBS311
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
DIHYDROXYALUMINUM AMINOACETATEInactive
Code: DO250MG0W6
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
ETHYLHEXYLGLYCERINInactive
Code: 147D247K3P
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
KAOLINInactive
Code: 24H4NWX5CO
Classification: IACT
2-ETHYLHEXYL ACRYLATE, METHACRYLATE, METHYL METHACRYLATE, OR BUTYL METHACRYLATE/HYDROXYPROPYL DIMETHICONE COPOLYMER (30000-300000 MW)Inactive
Code: S7ZA3CCJ4M
Classification: IACT
PHENOXYETHANOLInactive
Code: HIE492ZZ3T
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
SODIUM POLYACRYLATE (8000 MW)Inactive
Code: 285CYO341L
Classification: IACT
SORBITAN MONOOLEATEInactive
Code: 06XEA2VD56
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
TARTARIC ACIDInactive
Code: W4888I119H
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MENTHOLActive
Quantity: 5 mg in 100 mg
Code: L7T10EIP3A
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 8/11/2025

PRINCIPAL DISPLAY PANEL

Menthol 5% Hydrogel Patch Topical Analgesic - NDC 85267-003-01 - Pouch Label

!["Image Description"](/dailymed/image.cfm?name=menthol-hydrogel-patch- label.jpg&id=894097)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 8/11/2025

Use

For temporary relief of pain.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 8/11/2025

Manufactured By:
Novamed Laboratories Pvt. Ltd.
Plot No. 03, Sector 16, HSIIDC Industrial Estate,
Bahadurgarh, Haryana – 124507 (India)

MADE IN INDIA

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 8/11/2025

Active Ingredient Purpose

Menthol 5.0%........................................Topical analgesic

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 8/11/2025

WARNINGS SECTION

LOINC: 34071-1Updated: 8/11/2025

Warnings

For external use only

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 8/11/2025

Do not use

  • More than one patch on your body at a time
  • On cut, irritated or swollen skin
  • On puncture wounds
  • Over raw surfaces or blistered areas
  • For more than one week without consulting a doctor
  • If you are allergic to any active or inactive ingredients
  • If pouch is damaged or opened.

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 8/11/2025

When using this product

  • Use only as directed
  • Read and follow all directions and warnings on this carton
  • Do not allow contact with the eyes
  • Do not use at the same time as other topical analgesics
  • Do not bandage tightly or apply local heat (such as heating pads) to the area of use
  • Do not microwave
  • Dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 8/11/2025

Stop use and consult a doctor if

  • Condition worsens
  • Redness is present
  • Irritation develops
  • Symptoms persist for more than 7 days or clear up and occur again within a few days
  • You experience signs of skin injury, such as pain, swelling or blistering where the product was applied.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 8/11/2025

**If pregnant or breastfeeding,**ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 8/11/2025

**Keep out of reach of children and pets.**If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 8/11/2025

Directions

  • Adults and children 12 years of age and over: Clean and dry affected area, free of lotions, ointments and creams. Carefully remove backing from patch starting at a corner. Apply sticky side of patch to affected area. Do not use more than one patch in a 12 hour period. Maximum 2 patches per day. Discard patch after single use
  • Children under 12 years of age: consult a physician.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 8/11/2025

Other Information

Store in a clean, dry place outside of direct sunlight. Protect from excessive moisture.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 8/11/2025

Inactive Ingredients

alcohol, aluminum glycinate, benzyl alcohol, carboxymethylcellulose sodium, edetate disodium, ethylhexylglycerin, glycerin, isopropyl myristate, kaolin, methacrylate copolymer, phenoxyethanol, polysorbate 80, povidone, sodium polyacrylate, sorbitan monooleate, sorbitol, tartaric acid, titanium dioxide, water

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 8/11/2025

Questions or Comments****Call +91 1276 457643

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.